SPOTLIGHT: Gemzar effective in cancer study

Eli Lilly's chemotherapy drug Gemzar was effective in delaying the recurrence of pancreatic cancer in a new study. Median disease-free survival time for volunteers taking Gemzar was 13.4 months compared to 6.9 months for the control group. Report

Suggested Articles

Tango Therapeutics is ditching its digs in Kendall Square to move into a new building in Boston’s Fenway neighborhood. Third Rock is coming, too.

The Japanese drugmaker pulled the trigger on the deal after getting a look at phase 1 data on the glutenase TAK-062.

Vanda Pharmaceuticals is hoping to try again with an amended trial after its experimental skin drug tradipitant failed a phase 3 test.